Enes Erul, Oncology Fellow at Ankara University, shared his recent article on X:
“Our latest publication explores incidental (iHCC) in liver transplantation.
Key insights:
- iHCC prevalence: 1.6%-40%.
- USG often misses small tumors.
- The future: AI & liquid biopsy for better surveillance.“
The Impact of Incidental Hepatocellular Carcinoma in Liver Transplantation: A Growing Concern.
Authors: Alfredo Caturano, et al.
